These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38658533)

  • 21. Modulation of Mitochondrial ERβ Expression Inhibits Triple-Negative Breast Cancer Tumor Progression by Activating Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Kim JE; Han J; Kim TH; Jang SW
    Cell Physiol Biochem; 2019; 52(3):468-485. PubMed ID: 30873822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer.
    Li S; Wei Q; Li Q; Zhang B; Xiao Q
    Cancer Biol Ther; 2015; 16(6):866-75. PubMed ID: 25920936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
    Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC
    Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway.
    Tseng CW; Kuo WH; Chan SH; Chan HL; Chang KJ; Wang LH
    Cancer Res; 2018 Jun; 78(11):2799-2812. PubMed ID: 29599405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer.
    Qiao S; Lu W; Glorieux C; Li J; Zeng P; Meng N; Zhang H; Wen S; Huang P
    Oncogene; 2021 Sep; 40(39):5880-5892. PubMed ID: 34349242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isocitrate dehydrogenase 2 regulates the proliferation of triple-negative breast cancer through the ferroptosis pathway.
    Zhang C; Zhou Y; Chen T; Bhushan S; Sun S; Zhang P; Yang Y
    Sci Rep; 2024 Feb; 14(1):4732. PubMed ID: 38413708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells.
    Smolková K; Dvořák A; Zelenka J; Vítek L; Ježek P
    Int J Biochem Cell Biol; 2015 Aug; 65():125-33. PubMed ID: 26007236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
    Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
    Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review.
    Liu L; Bai J; Hu L; Jiang D
    Medicine (Baltimore); 2023 Oct; 102(43):e35493. PubMed ID: 37904441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy.
    Liu Q; Guan C; Liu C; Li H; Wu J; Sun C
    Biomed Pharmacother; 2022 Dec; 156():113861. PubMed ID: 36228375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts.
    Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB
    J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-183 upregulates HIF-1α by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells.
    Tanaka H; Sasayama T; Tanaka K; Nakamizo S; Nishihara M; Mizukawa K; Kohta M; Koyama J; Miyake S; Taniguchi M; Hosoda K; Kohmura E
    J Neurooncol; 2013 Feb; 111(3):273-83. PubMed ID: 23263745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
    Shi F; He Y; Li J; Tang M; Li Y; Xie L; Zhao L; Hu J; Luo X; Zhou M; Liu N; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Jia W; Bode AM; Cao Y
    Mol Metab; 2020 Jun; 36():100966. PubMed ID: 32224436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LINC00571 drives tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK/ILF2/IDH2 axis.
    Xi Z; Huang H; Hu J; Yu Y; Ma X; Xu M; Ming J; Li L; Zhang H; Chen H; Huang T
    J Exp Clin Cancer Res; 2024 Jan; 43(1):22. PubMed ID: 38238853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m
    Yu Y; Deng H; Wang W; Xiao S; Zheng R; Lv L; Wang H; Chen J; Zhang B
    Clin Transl Med; 2024 Feb; 14(2):e1583. PubMed ID: 38372449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer.
    Hao Y; Samuels Y; Li Q; Krokowski D; Guan BJ; Wang C; Jin Z; Dong B; Cao B; Feng X; Xiang M; Xu C; Fink S; Meropol NJ; Xu Y; Conlon RA; Markowitz S; Kinzler KW; Velculescu VE; Brunengraber H; Willis JE; LaFramboise T; Hatzoglou M; Zhang GF; Vogelstein B; Wang Z
    Nat Commun; 2016 Jun; 7():11971. PubMed ID: 27321283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reductive TCA cycle metabolism fuels glutamine- and glucose-stimulated insulin secretion.
    Zhang GF; Jensen MV; Gray SM; El K; Wang Y; Lu D; Becker TC; Campbell JE; Newgard CB
    Cell Metab; 2021 Apr; 33(4):804-817.e5. PubMed ID: 33321098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer.
    Li J; He Y; Tan Z; Lu J; Li L; Song X; Shi F; Xie L; You S; Luo X; Li N; Li Y; Liu X; Tang M; Weng X; Yi W; Fan J; Zhou J; Qiang G; Qiu S; Wu W; Bode AM; Cao Y
    Theranostics; 2018; 8(15):4050-4061. PubMed ID: 30128035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential.
    Pelicano H; Zhang W; Liu J; Hammoudi N; Dai J; Xu RH; Pusztai L; Huang P
    Breast Cancer Res; 2014 Sep; 16(5):434. PubMed ID: 25209360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reverse TCA cycle flux through isocitrate dehydrogenases 1 and 2 is required for lipogenesis in hypoxic melanoma cells.
    Filipp FV; Scott DA; Ronai ZA; Osterman AL; Smith JW
    Pigment Cell Melanoma Res; 2012 May; 25(3):375-83. PubMed ID: 22360810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.